Table 3.
Number of studies and comparative analysis corresponding to different outcome indicators.
| Outcomes | Number of studies | Number of meta-analyses compared to the control group |
|---|---|---|
| HbA1c | 40 | 56 |
| 2-h PBG | 33 | 40 |
| BMI | 7 | 8 |
| FBG | 42 | 71 |
| HDL-C | 9 | 12 |
| HOMA-IR | 9 | 11 |
| LDL-C | 14 | 16 |
| TC | 21 | 31 |
| TG | 21 | 35 |
| INS | 11 | 11 |
| 2 h postprandial insulin | 3 | 3 |
| Blood sugar target time | 2 | 2 |
| Average insulin dose | 1 | 1 |
| ISI | 7 | 7 |
| HOMA-β | 5 | 5 |
| Number/rate of hypoglycemia | 3 | 3 |
| Clinical efficacy | 13 | 16 |
| TCM syndrome | 10 | 10 |
| Follow-up | 1 | 1 |
| Sleep quality | 1 | 1 |
| Plasma viscosity | 1 | 1 |
| Fibrinogen | 1 | 1 |
| Quality of life | 1 | 1 |